Log in

NASDAQ:AMTX - Aemetis Stock Price, Forecast & News

$0.97
-0.04 (-3.96 %)
(As of 12/8/2019 07:40 AM ET)
Today's Range
$0.97
Now: $0.97
$1.02
50-Day Range
$0.95
MA: $1.00
$1.12
52-Week Range
$0.42
Now: $0.97
$1.70
Volume27,616 shs
Average Volume16,496 shs
Market Capitalization$19.95 million
P/E RatioN/A
Dividend YieldN/A
Beta0.23
Aemetis, Inc operates as a renewable fuels and bio-chemicals company in North America and India. The company focuses on the acquisition, development, and commercialization of various technologies that replace traditional petroleum-based products through the conversion of ethanol and biodiesel plants into advanced bio refineries. It owns and operates an ethanol plant in the California Central Valley near Modesto; and a biodiesel plant in Kakinada, India. Read More…

Industry, Sector and Symbol

Industry Industrial organic chemicals
Sub-IndustryN/A
SectorOils/Energy
Current SymbolNASDAQ:AMTX
CUSIPN/A
Phone408-517-3304

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$171.53 million
Book Value($5.68) per share

Profitability

Net Income$-33,020,000.00

Miscellaneous

Employees152
Market Cap$19.95 million
Next Earnings Date3/12/2020 (Estimated)
OptionableNot Optionable

Receive AMTX News and Ratings via Email

Sign-up to receive the latest news and ratings for AMTX and its competitors with MarketBeat's FREE daily newsletter.


Aemetis (NASDAQ:AMTX) Frequently Asked Questions

What is Aemetis' stock symbol?

Aemetis trades on the NASDAQ under the ticker symbol "AMTX."

How were Aemetis' earnings last quarter?

Aemetis Inc (NASDAQ:AMTX) announced its quarterly earnings results on Thursday, November, 14th. The specialty chemicals company reported ($0.31) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.29) by $0.02. View Aemetis' Earnings History.

When is Aemetis' next earnings date?

Aemetis is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Aemetis.

Has Aemetis been receiving favorable news coverage?

Press coverage about AMTX stock has been trending extremely positive recently, InfoTrie reports. InfoTrie rates the sentiment of press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores nearest to five being the most favorable. Aemetis earned a coverage optimism score of 5.0 on InfoTrie's scale. They also gave news coverage about the specialty chemicals company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Aemetis.

Are investors shorting Aemetis?

Aemetis saw a decline in short interest during the month of November. As of November 15th, there was short interest totalling 82,900 shares, a decline of 8.3% from the October 31st total of 90,400 shares. Based on an average daily volume of 34,700 shares, the days-to-cover ratio is presently 2.4 days. Currently, 0.6% of the shares of the company are sold short. View Aemetis' Current Options Chain.

Who are some of Aemetis' key competitors?

What other stocks do shareholders of Aemetis own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Aemetis investors own include InterDigital Wireless (IDCC), Stag Industrial (STAG), Wirecard (WDI), Pacific Ethanol (PEIX), Procter & Gamble (PG), Gevo (GEVO), Magnegas Applied Tchnlgy Sltns (MNGA), NuCana (NCNA), Alcoa (AA) and Bank of America (BAC).

Who are Aemetis' key executives?

Aemetis' management team includes the folowing people:
  • Mr. Eric A. McAfee, Co-Founder, Exec. Chairman, CEO & Pres (Age 56)
  • Mr. Todd A. Waltz, Exec. VP, CFO & Sec. (Age 58)
  • Mr. Andrew B. Foster, Exec. VP & COO (Age 54)
  • Mr. Sanjeev Gupta, Exec. VP & MD, Chairman and Pres of Universal Biofuels Pvt. Ltd. (Age 59)

Who are Aemetis' major shareholders?

Aemetis' stock is owned by a number of of institutional and retail investors. Top institutional investors include CIBC Private Wealth Group LLC (5.12%). View Institutional Ownership Trends for Aemetis.

Which major investors are selling Aemetis stock?

AMTX stock was sold by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC. View Insider Buying and Selling for Aemetis.

How do I buy shares of Aemetis?

Shares of AMTX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Aemetis' stock price today?

One share of AMTX stock can currently be purchased for approximately $0.97.

How big of a company is Aemetis?

Aemetis has a market capitalization of $19.95 million and generates $171.53 million in revenue each year. Aemetis employs 152 workers across the globe.View Additional Information About Aemetis.

What is Aemetis' official website?

The official website for Aemetis is http://www.aemetis.com/.

How can I contact Aemetis?

Aemetis' mailing address is 20400 STEVENS CREEK BLVD SUITE 700, CUPERTINO CA, 95014. The specialty chemicals company can be reached via phone at 408-517-3304 or via email at [email protected]


MarketBeat Community Rating for Aemetis (NASDAQ AMTX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  127 (Vote Outperform)
Underperform Votes:  155 (Vote Underperform)
Total Votes:  282
MarketBeat's community ratings are surveys of what our community members think about Aemetis and other stocks. Vote "Outperform" if you believe AMTX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AMTX will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel